Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults

Area of Science:

• Endocrinology
• Metabolic Medicine
• Pharmacotherapy

Background:

• Growth hormone (GH) replacement therapy is common for adult hypopituitarism, but optimal dosing remains unclear.
• Current weight-based or surface area-based dosing may lead to overtreatment.
• Individual variations in GH susceptibility, including gender differences, are increasingly recognized.

Purpose of the Study:

• To optimize GH replacement therapy in adult-onset hypopituitary patients.
• To explore gender-specific differences in GH susceptibility.
• To compare a novel dose titration regimen with conventional weight-based dosing.

Main Methods:

• A dose titration regimen was initiated in 50 adult-onset hypopituitary patients.
• Serum insulin-like growth factor I (IGF-I) levels were monitored bi-weekly to guide dose adjustments.
• The regimen aimed to maintain IGF-I levels between the median and upper end of the age-related reference range.

Main Results:

• The dose titration regimen achieved significantly lower median maintenance GH doses compared to weight-based regimens.
• Females required significantly higher maintenance GH doses than males, indicating decreased overall sensitivity.
• The titration regimen led to rapid achievement of target IGF-I levels, with no loss of efficacy in improving body composition and well-being.

Conclusions:

• A uniform GH dose titration regimen based on serum IGF-I is effective and leads to lower maintenance doses.
• This method optimizes GH replacement therapy, especially in female patients who exhibit reduced GH sensitivity.
• The titration approach provides a practical and efficient strategy for managing adult hypopituitarism.